Liver metastasis represents a common systemic complication of colorectal cancers (CRCs).
Partial liver resection has been demonstrated to result in long‐term survival in certain well …

Introduction Liver resection (LR) in patients with liver metastasis from colorectal cancer
remains the only curative treatment. Perioperative chemotherapy improves prognosis of …

Background/Aim: Nowadays, obtaining optimal surgical margin of the resected metastasis
and the parenchyma-sparing surgical technique are a great challenge for hepatic surgeons …

Hepatocellular carcinoma (HCC) treatment is challenging because the mechanisms
underlying tumor progression are still largely unknown. Transforming growth factor (TGF) …

BACKGROUND: It is reported that hepatic ischemia/reperfusion (I/R) during hepatectomy
accelerates liver tumor growth. Hepatic I/R induces inflammation cytokines, which can …

Background Some chemotherapeutic agents have been reported to promote lung
metastasis. However, there have been no reports regarding chemotherapy-induced liver …

Some investigators have suggested that preoperative chemotherapy for hepatic colorectal
metastases may cause hepatic injury and increase perioperative morbidity and mortality …

Background: A survival benefit is generally considered unobtainable following incomplete
hepatic resection in patients with colorectal liver metastases. However, this question should …

Although resection remains the only potentially curative treatment for most patients with
primary and secondary liver malignancies, the large majority of patients will experience …

At diagnosis of colorectal cancer, approximately 25% of the patients have established
colorectal liver metastasis. Optimal management of disseminated disease requires therapies …